Press
back to blog

Entos (now Iambic) Included in Business Insider's List of Most-Promising Healthcare Start-Ups of 2023

Press
This is some text inside of a div block.
July 19, 2023

Media Contacts

Related announcements

View All
View All
December 11, 2024

Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer

Read more
December 11, 2024

Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer

Read more
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more